MORE►
Novartis AG
Dr. David Genecov, left, and John Harkey of Dialectic Therapeutics. [Photos: Courtesy Dialectic Therapeutics]
Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award
by Lance Murray | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
by Lance Murray |
Oct 25, 2018
You'll also find news from WiredScore, Jacobs Engineering, BNSF Railway and GE Transportation, as well as Bay Capital Ventures and Eyevance. Here are notable funding and acquisition deals with North Texas ties.
MORE►
